![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 25, 22520-22527, June 21, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of Microbiology and Biochemistry, University
of Illinois, Urbana, Illinois 61801
Received for publication, February 6, 2002, and in revised form, March 29, 2002
Biotin carboxyl carrier protein
(BCCP) is the small biotinylated subunit of Escherichia
coli acetyl-CoA carboxylase, the enzyme that catalyzes the
first committed step of fatty acid synthesis. E. coli BCCP
is a member of a large family of protein domains modified by covalent
attachment of biotin. In most biotinylated proteins, the biotin moiety
is attached to a lysine residue located about 35 residues from the
carboxyl terminus of the protein, which lies in the center of a
strongly conserved sequence that forms a tightly folded anti-parallel
Biotin and lipoic acid are vitamins that play essential roles in
central metabolism. The biological activities of both coenzymes are
dependent upon their covalent attachment to their cognate proteins (1).
In both cases, the site of coenzyme attachment is the Acetyl-CoA carboxylase (ACC) catalyzes the first step in fatty acid
synthesis, the synthesis of malonyl-CoA from acetyl-CoA (12) (Fig.
2). ACC is a biotin-dependent
enzyme, and like all biotin enzymes, the cofactor must be covalently
attached to ACC for enzyme activity. In E. coli and many
other bacteria, the functional enzyme consists of two copies of each of
four different subunits (13-15). The biotin cofactor is attached to
the biotin carboxyl carrier protein (BCCP) subunit, the sole
biotinylated protein of this organism (Fig. 2). In the first partial
reaction, the heterocyclic ring of the attached biotin moiety is
carboxylated by the biotin carboxylase subunit. The carboxyl group is
then transferred from biotin to acetyl-CoA to produce malonyl-CoA by carboxyltransferase, a complex of two proteins called
Interchangeable Enzyme Modules
FUNCTIONAL REPLACEMENT OF THE ESSENTIAL LINKER OF THE
BIOTINYLATED SUBUNIT OF ACETYL-CoA CARBOXYLASE WITH A LINKER FROM THE
LIPOYLATED SUBUNIT OF PYRUVATE DEHYDROGENASE*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-barrel structure. Located upstream of the conserved biotinoyl
domain sequence are proline/alanine-rich sequences of varying lengths,
which have been proposed to act as flexible linkers. In E. coli BCCP, this putative linker extends for about 42 residues
with over half of the residues being proline or alanine. I report that
deletion of the 30 linker residues located adjacent to the
biotinoyl domain resulted in a BCCP species that was defective in
function in vivo, although it was efficiently biotinylated. Expression of this BCCP species failed to restore normal growth and fatty acid synthesis to a temperature-sensitive E. coli strain that lacks BCCP when grown at nonpermissive
temperatures. In contrast, replacement of the deleted BCCP linker with
a linker derived from E. coli pyruvate dehydrogenase gave a
chimeric BCCP species that had normal in vivo function.
Expression of BCCPs having deletions of various segments of the linker
region of the chimeric protein showed that some deletions of up to 24 residues had significant or full biological activity, whereas others
had very weak or no activity. The inactive deletion proteins all lacked an APAAAAA sequence located adjacent to the tightly folded biotinyl domain, whereas deletions that removed only upstream linker sequences remained active. Deletions within the linker of the wild type BCCP
protein also showed that the residues adjacent to the tightly folded
domain play an essential role in protein function, although in this
case some proteins with deletions within this region retained activity.
Retention of activity was due to fusion of the domain to upstream
sequences. These data provide new evidence for the functional and
structural similarities of biotinylated and lipoylated proteins and
strongly support a common evolutionary origin of these enzyme subunits.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-amino group
of a lysine residue centrally located within conserved sequences of
~70 amino acid residues that fold to form discrete protein domains.
The three-dimensional structures of both biotinoyl (2-6) and lipoyl
domains (7-9) from several biological sources have been determined,
and the structures are largely superimposable. Indeed, Reche and Perham
(10) have succeeded in altering the Escherichia coli
acetyl-CoA carboxylase (ACC)1
biotinoyl domain such that the normally absolutely specific lipoate protein ligase will attach lipoic acid to various mutant biotinoyl domains. Therefore, it seems clear that two enzyme families that catalyze very different reactions use a common structural domain to
carry the essential coenzyme. Biotinylated enzymes catalyze carboxylation and decarboxylation reactions and play essential roles in
fatty acid synthesis and amino acid degradation, whereas lipoylated
enzymes catalyze acyl transfer and single carbon transfer reactions and are required for function of the citric acid and glycine
cleavage cycles (1). Both the biotinoyl and lipoyl domains are thought
to act as swinging arms that convey covalently bound intermediates
between different active sites of a multienzyme complex (1). Swinging
arm mobility has two different aspects. Mobility on a small scale is
imparted by attachment of the carboxyl of the coenzyme to the
-amino
group of a lysine residue located at the tip of a protruding
-turn.
As first proposed (see Ref. 11) this arrangement gives the "business
ends" of the coenzymes a significant reach. Mobility on a much larger
scale is imparted by the proline plus alanine-rich sequences adjacent
to the lipoyl domains that act as flexible linkers (Fig. 1) (1). In
lipoyl enzymes having only a single domain, the domain forms the amino terminus of the protein, and the linker connects the domain to the
catalytic domain of the protein. In proteins having multiple lipoyl
domains, such as E. coli pyruvate dehydrogenase (PDH), which
has three lipoyl domains, the domains are arranged in tandem at the
amino terminus with linkers separating the domains from one another and
from the catalytic domain (Fig. 1B). Biotinylated proteins
are the mirror image of the single lipoyl domain proteins; the modified
domain is located at the carboxyl terminus, and a proline plus
alanine-rich sequence is found upstream of the domain (Fig.
1A).

View larger version (16K):
[in a new window]
Fig. 1.
Diagrams of the E. coli
BCCP and PDH E2 proteins and their linker sequences.
A, BCCP with the domain shown as an oval, the
linker as the wavy line, and the biotin as
. A
putative interaction domain at the N terminus is depicted by a
rectangle. B, the PDH E2 subunit using the same
depictions except that coenzyme is depicted by
. C, the
sequences of the PDH E2 linkers; D, the residue
substitutions made in replacing the BCCP linker with that from
PDH-1.
and
. Similar ACCs (referred to as heteromeric ACCs) are found in the chloroplasts of many plants (16). The structure of the biotinoyl domains of the E. coli acetyl-CoA subunit, BCCP (also called
AccB) (2, 4-6) and a related protein, the Propionibacterium
shermanii 1.3 S transcarboxylase subunit (3), have been
determined. In both cases, the structures of the protein segments
located upstream of the biotinoyl domain could not be determined due to
their high degree of mobility. No structures could be detected in these
protein segments by either x-ray diffraction or multidimensional
heteronuclear NMR spectroscopy.

View larger version (13K):
[in a new window]
Fig. 2.
The reaction mechanism of E. coli acetyl-CoA carboxylase. BCCP is encoded by
the accB gene, whereas biotin carboxylase is encoded by the
accC gene (15). The two subunits involved in
carboxyltransferase activity are encoded by the accA and
accD genes (14). The covalently bound biotin of BCCP carries
the carboxylate moiety.
Given the similarities between the biotinoyl and lipoyl domains, it seemed plausible that the putative biotinoyl domain linker regions might play roles similar to those of the lipoyl domain linkers. However, an argument against this notion is that the sequences of biotinoyl and lipoyl linkers cannot be aligned for more than a few residues (Fig. 1). Moreover, in the linkers of some biotinoyl proteins, other small residues (generally serine or glycine) have replaced alanine, and the linkers of lipoyl proteins are richer in charged residues than are the biotinoyl linkers. On the other hand, given the conserved domain structures, it seemed unlikely that the conserved proline/alanine-rich nature of the neighboring amino acid sequences could be accidental. The E. coli PDH linkers (Fig. 2A) have been extensively studied, and the available data indicate that the combination of proline and alanine results in an extended, but flexible, structure (1, 17-25). In the E. coli PDH complex, the linker regions are known to be highly mobile and exposed to solvent. The mobility of these linker regions was first detected by NMR studies of the intact complex (20, 21). Despite the very high molecular weight of the E. coli PDH complex (5-10 × 106), a set of sharp resonances are observed that disappear with loss of the lipoyl domains (from proteolytic cleavages within the linkers). Moreover, the spectra observed in the intact complex are essentially the same as those of synthetic linker peptides (17, 23).
In this paper, I report that a large deletion of the putative linker
region of the E. coli BCCP subunit results in a protein of
extremely compromised ACC activity in vivo. However,
biological activity was restored upon insertion of a sequence derived
from the first linker of the E. coli PDH E2 subunit,
indicating that the lipoyl and biotinoyl linker regions have
overlapping functions. Deletion and insertion analyses of this chimeric
protein and of the native BCCP showed that only a restricted portion of
the linker was required for biological activity and that many sequences
fail to provide linker function.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Construction of an accB Gene Encoding a PDH Linker-- The synthetic 133-bp linker was constructed in three stages due to its length. First, a cassette encoding the N-terminal end of the linker was produced by annealing the complementary oligonucleotides 1 and 2 (Table I) and ligating this to pMTL22 (26) digested with the HindIII and NgoMIV (the cassette was designed such that complementary ends would result upon annealing). Likewise, a cassette encoding the C-terminal end of the linker was produced by annealing oligonucleotides 3 and 4 and was ligated to pK19 (27) digested with NgoMIV plus SmaI. Ligation to the SmaI end resulted in construction of a BsiWI site. The plasmids encoding the N-terminal and C-terminal halves of the linkers were then digested with NgoMIV and HindIII or BsiWI, respectively; the linker-encoding fragments were purified, mixed in equimolar ratios, and then ligated together with the accB plasmid pCY326 (28) digested with HindIII and BsiWI in a three partner ligation. The resulting plasmids were sequenced and found to contain a 179-bp vector-derived sequence inserted between the two linker-encoding fragments. This vector fragment insert (apparently due to a mutation at the NgoMIV end of the C-terminal cassette) was removed by digesting the plasmid with NgoMIV and BglII and inserting a cassette of annealed oligonucleotides 5 and 6 to give the desired linker sequence. Two other plasmids were also derived by cassette mutagenesis. A cassette encoding the sequence PAAAA was obtained by annealing oligonucleotides 7 and 8 and inserting this cassette into BglI-digested pCY326 (the cassette was designed with complementary ends and included a new BstZI site and retained the BglI site at one end of the inserted sequence). Finally, a cassette designed to delete the EAPAAA sequence adjacent to the biotinoyl domain of the wild type gene was obtained by annealing oligonucleotides 9 and 10 and ligating this product to pCY326 digested with NcoI and BsiWI. This cassette introduced a BglII site and inactivated the BsiWI site.
|
A series of deletions within the region encoding the chimeric linker
were made by restriction digestion followed by blunt end ligation done
at low DNA concentrations to favor recircularization. In most cases,
one or both of the ends resulting from digestion were either filled in
or resected by treatment with either phage T4 DNA polymerase plus the
four nucleoside triphosphates or by treatment with mung bean nuclease
in order to give the proper reading frame. The 3' to 5' exonuclease
activity of the polymerase was used to remove 3'-extensions, whereas
5'-extensions were removed by mung bean nuclease. For brevity, the
abbreviations T4 and MB following the restriction enzyme used to
generate the extension will be used to signify these manipulations (the
conditions used are given below). The constructions were as follows:
1, HindIII(T4) and PstI(T4);
2,
FspI and NaeI;
4, FspI and
BglII(T4);
5, BstAPI(T4);
6,
HindIII(T4) and NgoMIV(T4);
8,
BsgI(T4) and PstI(T4);
9, NgoMIV(MB) and BglII(MB);
10,
NgoMIV(MB) and PstI(T4);
11,
HindIII(MB) and FspI;
12,
HindIII(MB) and NaeI;
13,
HindIII(T4) and BglII(T4). The
15 plasmid
resulted from the same manipulations as
10 but suffered a 27-bp
deletion presumably via illicit recombination in vivo.
A series of manipulations of the wild type BCCP linker region were also
made. The construct encoding the
14 BCCP resulted from digestion of
pCY326 with NcoI followed by MB treatment. The MB was
inactivated, and the DNA was digested with HindIII, treated with T4, and ligated. The construct encoding the
17 BCCP resulted from annealing the complementary oligonucleotides 9 and 10 and ligating
the cassette to pCY326 digested with NcoI plus
BsiWI (the annealed cassette was designed such that
complementary ends would result). The
18 and
19 BCCP constructs
were made by insertion of antibiotic cassettes into the introduced
BglII site of the
17 construct. The BamHI
tetracycline resistance-encoding fragment of p34s-Tet (29) was ligated
to the BglII-cut
17 plasmid followed by selection for
resistance to both tetracycline and kanamycin. The tetracycline
resistance determinant was then eliminated by SstI digestion
and ligation. The construction of
19 followed a similar route except
that the SstI tetracycline resistance fragment p34s-Tet was
flanked by two copies of the BglII-SstI fragment of the multiple cloning site of pMTL25 (26). The tetracycline determinant was then eliminated by MluI digestion followed
by ligation to give the construct encoding
19. Construction of the genes encoding the
20,
21,
22, and
23 BCCPs used a 12-bp
cassette made by annealing the complementary oligonucleotides 7 and 8 followed by treatment with MB and phage T4 polynucleotide kinase plus
ATP. The blunt-ended cassette was then ligated to pCY326 digested with NcoI plus BsiWI and treated with T4. DNA
sequencing showed three different products: insertion of one copy of
the cassette in the two possible orientations (
22 and
22) and two
copies inserted in a head to tail configuration (
21). The gene
encoding
21 was then cut with PstI and religated to give
23. The genes encoding
24 and
27 were derived from that
encoding
23 by insertion of the gentamycin resistance encoding the
PstI fragment of p34s-Gm (29) into the PstI site
of the
23 construct. The resistance gene was then removed by
digestion with XbaI digestion to give
25 or
SstI digestion to give
27. The gene encoding
26
resulted from insertion of the same oligonucleotide cassette as
17
except that the sticky ends were removed by T4 treatment, and the
resulting blunt end cassette was ligated to pCY326 digested with
NcoI plus BsiWI and then treated with T4. The
resulting recombinant plasmids were then screened for products with the
cassette inserted in the orientation opposite that of
17. The gene
encoding the I28 insertion was constructed by annealing the
complementary oligonucleotides 7 and 8 and ligating the resulting
cassette to pCY326 digested with BglI. The gene encoding the
BCCP-P. shermanii 1.3 S chimeric protein was constructed
from pCY325 (28) and p1.3t (30) by ligating the
SalI-BglII fragment of p1.3t into pMTL21 digested with SalI plus BamHI. The resulting plasmid was
digested with EcoRI and BamHI and ligated to the
EcoRI-BglII accB fragment of pCY325.
This plasmid was digested with NcoI (which cuts within accB) and KasI (which cuts within the 1.3 S
coding sequence), and a cassette made by annealing the complementary
oligonucleotides 11 and 12 was then inserted by ligation.
Screening of Deleted Plasmids-- The products of most of the deletion/insertion ligations were transformed into strain CY1478, which carries a chromosomal bioBFC-lacZ fusion and overproduces lacI repressor from an F' episome. Strain CY1478 was constructed by conjugational mating of strain BM2661 (31) with NovaBlue (Novagen) with selection for recombinants resistant to streptomycin and tetracycline to introduce the lacIQ episome. The transformants were tested on RB medium containing 80 nM biotin and X-gal (40 µg/ml), ampicillin, and tetracycline. Colonies were patched onto two plates of this medium, one supplemented with glucose (0.4% final concentration) and the other lacking glucose. The plates were then incubated at 37 °C overnight. Colonies that were very dark blue on the plate lacking glucose but pale blue on the glucose-containing plates were in frame deletions, whereas colonies that were white on both plates were out of frame fusions (the rationale is explained under "Results"). The lacIQ episome was introduced to decrease expression from the vector lac promoter, which is responsible for BCCP expression in pCY326 and its derivatives. Glucose addition was used to further decrease BCCP expression by decreasing cAMP-dependent expression from the lac promoter. Low level BCCP expression was desired, because high level expression of this protein is toxic to E. coli and also to allow colony scoring by use of X-gal. All constructs were confirmed by DNA sequencing done by the Keck Genomics Center of the University of Illinois. Treatment with T4 DNA polymerase (New England Biolabs) was done in the restriction enzyme digestion buffer supplemented with the four deoxynucleotide triphosphates each at 0.25 mM. One unit of polymerase was added, and the reaction was incubated at 16 °C for 15-30 min followed by phenol treatment to inactivate the polymerase. Treatment with mung bean nuclease (New England Biolabs) was done in the restriction enzyme digestion buffer supplemented with 1 mM ZnSO4. Ten units of nuclease were added, followed by incubation at 30 °C for 1 h and then phenol extraction to inactive the nuclease.
Protein Expression-- Each of the altered accB genes was cloned together with the downstream kanamycin resistance gene into the regulated expression vector pCY465 (28) as previously described.
Other Methods--
Measurement of protein biotinylation by
labeling growing cultures with [8,9-3H]biotin, gel
electrophoresis, fluorography, and bacterial media were as described
previously. A sample of BCCP-87 mixed with the full-length BCCP was
made by IPTG induction of strain TM126, a wild type strain carrying
pTM52 (32) in [3H]biotin-containing medium. Plasmid pTM52
was constructed by insertion of the BCCP-87 encoding
NcoI-HindIII segment of pLS4 (15) into expression
vector pKK233-2 (33) cut with the same enzymes.
| |
RESULTS |
|---|
|
|
|---|
Essential Nature of the BCCP Linker--
The determined structures
of the BCCP biotin domain begin at residues Gly77 and
Ile78, although these residues and the next few residues
(up to Ile82) are considerably more mobile than the
residues of the tightly folded domain (2, 4-6). In preliminary work,
the accB gene was modified to introduce a BglII
site that overlapped codons 77 and 78. The DNA segment lying between
this new site and the naturally occurring HindIII site was
then deleted by restriction digestion followed by treatment with phage
T4 DNA polymerase plus the four deoxynucleotide triphosphates and phage
T4 DNA ligase. These manipulations removed most of the putative linker
region. It should be noted that this construct would not be expected to produce an active BCCP species, because the translation frame would be
out-of-frame relative to the accB coding sequence. However, such in vitro filling and ligation reactions have a
significant error rate such that rare in-frame constructs were expected
(34). In-frame constructs were detected by use of the biotin operon regulatory system (35-37). Overproduction of a biotin acceptor protein
results in increased expression of the biotin biosynthetic operon due
to consumption of biotinyl-AMP by protein biotinylation (37). This
increase in transcription is readily detected by use of a host strain
(strain CY1478) carrying a promoter fusion construct in which a biotin
operon promoter drives expression of E. coli
-galactosidase (31). The increased biotin operon expression is
detected by increased cleavage of a chromogenic
-galactosidase
substrate. In the present case, correctly processed constructs would be
out-of-frame, and the lack of a biotin domain expression would result
in white colonies on medium containing X-gal, whereas the rare in-frame
constructs that accepted biotin (and thereby result in increased biotin
operon expression) would give blue colonies. This screen was used in
the construction of the deletions reported below, and all blue colonies
were shown by DNA sequencing to have in-frame sequences (a few pale
blue colonies were found to encode out-of-frame constructs). In the case of the HindIII-BglII deletion, DNA
sequencing showed an in-frame construct (called
13) that removed 30 residues of the putative BCCP linker and resulted from incomplete
filling of the BglII site.
The function of the
13 construct and the other constructs in this
paper were tested in vivo as described previously (28). In
brief, the altered accB genes were inserted into an
expression plasmid that expressed the altered BCCP at a level
comparable with that from the wild type chromosomal accB
gene. The expression constructs where then transformed into E. coli accB mutant strain, CY1336, which encodes a
temperature-sensitive BCCP (G133S BCCP) that is rapidly degraded upon
shift to 37 °C (or higher temperatures). In the absence of
expression of a functional plasmid-encoded BCCP gene, strain CY1336
fails to grow, whereas expression of a functional protein permits
growth (hence giving genetic complementation of the host
accB mutation). At 37 °C, growth was found to require about 8% of the normal level of BCCP (28). Strain CY1336 expressing the wild type gene grows well at 37 °C and appreciably more slowly at 42 °C.
When the
13 BCCP was expressed in strain CY1336, the strain grew
very poorly at 37 °C and failed to grow at 42 °C (Fig.
3, A and B). As
expected from prior work (28), the barely detectable growth of the
strain observed at 37 °C required induction of gene expression with
IPTG. Therefore, deletion of the BCCP linker residues resulted in a
protein that was virtually without activity in vivo.
|
Functional Replacement of the BCCP Linker with Linker 1 of the E. coli PDH E2p Subunit-- Two approaches were considered to dissect the role of the linker region in BCCP function. The first approach was a conventional deletion analysis, but this was inconvenient due to a scarcity of restriction sites in the sequence encoding the linker. A second approach was to substitute a known linker sequence for that of BCCP and thereby obtain a well studied linker. This second approach was taken and the coding sequence of the chosen linker was redesigned to include useful restriction sites. In this construct, 28 residues of the putative linker of BCCP were replaced with the sequence that links the outermost two lipoyl domains of E. coli pyruvate dehydrogenase (Fig. 1). This linker was chosen over the other two E. coli PDH E2p linkers, since its length was exactly that of the proline/alanine-rich region of BCCP, and thus no artificial truncation or extension was required to fit this linker into BCCP. The restriction sites were included to simplify manipulations of the amino acid sequence. If insertion of the new linker allowed biological function of the chimeric BCCP, then construction of deletions that resulted in loss of function could define the important parts of the linker. If, on the other hand, the chimeric BCCP was nonfunctional, substitutions with segments of the BCCP sequence could be made in attempts to restore function.
The striking result was that the chimeric BCCP was fully functional at both 37 and 42 °C in vivo, indicating that the proline/alanine-rich regions of BCCP and PDH linker 2 functioned in a similar manner. Given this result and the prior studies demonstrating mobility and flexibility of the PDH linkers both in situ and as isolated peptides, it can be confidently predicted that upon structural analysis, the proline/alanine-rich region of BCCP shall be found to be a mobile linker.
Essential Segments of the Chimeric BCCP Linker Region-- A series of deletions were made within and upstream of the linker region of the chimeric protein by use of the introduced restriction sites. These deletions were all made upstream of Gly80, the first highly structured residue of the conserved domain (2, 4-6), since prior work had shown that deletion of residues at the amino or carboxyl ends of biotinoyl domain sequences results in the loss of biotinylation due to loss of domain structure (37, 38). Although BCCP residues 77-79 have defined secondary structures, these residues were considered candidates for deletion or substitution, since the residues are extended from (and do not interact with) the main body of the domain protein and have been considered as part of the linker region (4). These residues are highly mobile in the NMR analyses and have high crystallographic B values and thus seemed reasonable candidates for deletion or substitution. Moreover, these residues are not conserved in the BCCPs of Pseudomonas aeruginosa (39) and Bacillus subtilis (40), both of which have been shown to fully replace the function of E. coli BCCP in vivo (the latter protein also has a one-residue deletion within this segment). Finally, none of the BCCP residues upstream of residue 81 show any structure-based alignment with the other biotinyl domain of known structure, the P. shermanii 1.3 S trancarboxylase subunit (28), indicating that these residues do not play a role in biotin domain structure.
Upon construction and testing in vivo function of a number
of constructs (Figs. 3 and 4 and Table
II), BCCP function was found to
tolerate rather large deletions, whereas
some small deletions gave nonfunctional
or poorly functional BCCPs. For example, expression of the
1 and
6 BCCPs, containing deletions of 23 and 19 residues, respectively,
resulted in normal growth of CY1336 at 37 and 42 °C, whereas
15,
a smaller deletion of only nine residues, completely failed to support
growth. The deletions (
4,
13, and
15) that were the most
defective in supporting growth of CY1336 lacked the sequence of four
consecutive alanine residues located just upstream of the biotinoyl
domain. This region seemed very sensitive to sequence alterations,
since deletions that fused the biotinoyl domain to an AAP sequence
(
15), an AAPA sequence (
4), or a single alanine (
13) were all
inactive. In contrast, deletions of upstream proline/alanine sequences
as in the
1,
2,
5,
6,
11, and
12 BCCPs had little or
no effect on growth. The only exception to this picture was
8, a
deletion of 29 residues. Although in
8 the sequences just upstream
of the biotinoyl domain were left intact, expression of the mutant BCCP
resulted in only slow growth of CY1336 at 37 °C. However,
interpretation of this result is not straightforward, since expression
of the
8 BCCP also allowed growth at 42 °C (all other constructs
that grew poorly at 37 °C failed to grow at the higher temperature).
Note that an observed lack of activity in the biological test system
could be due to degradation of the altered proteins such as
endoproteolytic cleavage of the altered linker sequences. To test this
possibility, each of the constructs was expressed in strain CY1336 at a
nonpermissive temperature (so the chromosomally encoded G133S protein
would be degraded) and labeled with [3H]biotin, and the
radioactive proteins were analyzed by SDS-gel electrophoresis.
Expression of each of the deleted BCCPs at 38 °C in the presence of
[3H]biotin gave a radioactive band of the expected
electrophoretic mobility. Fig. 4 shows some of these data. Two of the
constructs (
1 and
2, data not shown) showed minor amounts of
smaller biotinylated proteins in addition to the full-length proteins
consistent with some endoproteolytic processing. However, the strains
expressing these proteins grew normally, and thus the loss of protein
due to processing was of no consequence.
|
|
Analysis of the Native BCCP Linker Region--
Deletion and
insertion studies were also done on the native BCCP linker. First,
based on the results obtained with the chimeric protein,
14, a
deletion similar to
13, but retaining the proline/alanine-rich sequence adjacent to the biotinoyl domain, was constructed. Expression of the
14 protein gave only modestly reduced growth, and thus restoration of only 7 of the 30 residues deleted in
13 resulted in
return of most of the biological activity. Of these seven residues, it
seemed likely (given the above results) that the APAAA sequence would
play an important role in this restoration of biological activity.
Therefore, this sequence was deleted from the native linker to give the
17 protein with the anticipation that this protein should show
decreased biological activity. However, expression of the
17 protein
gave essentially wild type growth (Fig. 3). Hence, the presence or
absence of APAAA sequences adjacent to the biotinoyl domain seemed to
give apparently conflicting results in
17 BCCP versus
13 BCCP. This apparent conflict could be explained if in
17 BCCP
upstream proline/alanine-rich sequences could functionally substitute
for the deleted residues, whereas in
13 no sequences were available
to act as surrogates of the deleted residues. To test whether upstream
residues were responsible for function of the
17 BCCP, two arbitrary
sequences were inserted adjacent to the biotinoyl domain of the
17
protein to act as possible spacers or insulators between the domain and
the upstream proline/alanine-rich sequences. The sequences used were
those encoded by symmetrical multiple cloning sites from two different
cloning vectors, and these were inserted immediately upstream of the
biotinoyl domain of
17 to give the
18 and
19 BCCPs. Although
expression of the
18 protein allowed growth at 37 °C, growth at
42 °C was greatly decreased. Upon expression of the
19 protein,
growth at 37 °C was almost normal, and growth also proceeded at
42 °C, albeit at a rate about 50-60% of that seen upon expression
of the wild type protein. Therefore, the sequence IPGYRARYPG of
18
acts as an effective barrier between the biotin domain and the upstream sequences. Note that the proteins with these altered linkers were well
expressed and stable in vivo (Fig. 4).
Other BCCP Constructs--
A number of other alterations of the
wild type BCCP sequence were made (data not shown). Several encoded
proteins were unstable or poorly biotinylated. However, four
constructs are worthy of note. Substitution of the EAPAAAEISGHI
sequence with NVTGDL (
26), LQRPRPLQ (
21), LQVDSRVDLQ (
25), or
NVTGDPRVPSSVPGDL (
20) gave proteins that were stable and well
biotinylated. However, upon expression, none of the three proteins
supported growth of strain CY1336. Therefore, residues 77-82 of BCCP
can be substituted with very different residues without major effects
on the structure of the biotinoyl domain as assayed by the sensitive
assays of biotinylation and stability to proteolysis in
vivo (36), and thus the lack of biological activity must be
attributed to the alterations of the linker. Finally, a more ambitious
chimeric protein was made in which the BCCP biotinoyl domain was
replaced with the only other biotinoyl domain of known structure, that of P. shermanii transcarboxylase (3). The fusion
junction between the two proteins was a structurally conserved glycine
residue such that the last residue of the BCCP linker,
Gly80, was replaced with Gly48 of the
transcarboxylase 1.3 S subunit. Upstream of this glycine residue were
the N-terminal 79 residues of BCCP, and downstream were the 75 C-terminal residues of the 1.3 S subunit biotinoyl domain. Expression
of this chimeric protein failed to allow any detectable growth of
mutant strain CY1336 at any nonpermissive temperature, although the
chimeric protein was stable and efficiently biotinylated. Therefore,
despite the conserved domain structure, the biotinoyl domain of BCCP
could not be functionally replaced with a foreign biotinoyl domain.
| |
DISCUSSION |
|---|
|
|
|---|
The proline/alanine-rich region of BCCP is essential for function of the protein as shown by the deletion analyses reported. The finding that a linker region from the E2 subunit of the PDH complex functionally substitutes for the natural region indicates that these protein segments play similar roles in the two enzyme complexes, although the cognate enzymes have markedly differing structures and catalytic activities. Since the structures of the biotinoyl and lipoyl domains can be largely superimposed, it seems that not only the domain structures, but also the structure of the linkers that connect these domains to their cognate proteins, have been conserved. Although the PDH linker functionally replaced that of BCCP, only borderline amino acid sequence conservation is seen between the BCCP and PDH linkers (Fig. 1). The lack of sequence conservation is not surprising, since little strict sequence conservation is found among the three linkers that connect the three E. coli lipoyl domains to the remainder of the E2 subunit (Fig. 1). Since there is also only marginal sequence conservation between the structurally homologous biotinoyl and lipoyl domains (41), it clearly is the structures rather than the sequences of these protein domains that have been conserved.
BCCP function is not dependent on the length of the linker region,
since proteins having a deletion of 23 residues (
1) and/or an
insertion of five residues (I28) were fully functional. Although a
defined overall length was not important, deletions of some linker
segments resulted in acute losses of function. Indeed, deletion within
the BCCP linker had much larger effects on in vivo function
than were observed in similar deletion analyses of PDH complexes
containing an E2p subunit having a single lipoyl domain (18, 19). In
the PDH case, 31 of the 32 linker residues had to be deleted before
growth of an E. coli strain requiring function of the
engineered E2p subunit was strongly affected. Smaller deletions had
only modest effects on growth. The effects on cell growth were
reflected in vitro assays of the overall PDH complex enzyme
activity, where a maximal effect of 3-fold was seen (19). The most
striking effect in these studies was obtained upon substitution of an
arbitrarily designed highly charged linker for the natural sequence.
This substitution abolished growth of the E. coli strain and
resulted in a PDH complex of greatly reduced activity (19). More
conservative substitutions such as linkers composed of virtually all
alanine residues or all proline residues resulted in highly active PDH
complexes that supported full cell growth, although both of these
synthetic linkers seemed less flexible than the native linkers (25).
Given the extremely permissive nature of permitted substitutions in the
PDH E2 linker regions as well as the weak dependence on the presence of
a linker, there seems little doubt that the BCCP linker region could
functionally replace one or all of the PDH E2 linkers. However, this
possibility has not yet been tested.
In contrast to results reported for the PDH complex, when placed in the context of BCCP, small deletions of the PDH linker could result in complete loss of protein function in vivo. The deletion analyses indicate that the sequence of four consecutive alanine residues adjacent to the biotinoyl domain plays the most important role of the linker in BCCP function. Since biotinylation of the domain by E. coli biotin protein ligase is not impaired by deletion of these residues and the altered proteins are stable in vivo, the defects must lie in the function of BCCP in the ACC reaction. A 26-residue synthetic peptide having the sequence of the PDH linker that was introduced into BCCP has been studied by physical techniques (23). Although the peptide has the circular dichroism and proton NMR spectra of a random coil, it cannot be viewed as a "wet noodle," since >95% of the Ala-Pro sequences are in the all-trans configuration, whereas the value expected for a random coil is lower by 10-15%. This skew toward the all-trans configuration suggests that the linker has a degree of order (23). From the known properties of proline peptides and alanine peptides, it is thought that the linker has a flexible and extended structure that allows mobility without collapsing upon itself. This picture also pertains to BCCP, since the PDH linker is a fully functional replacement for that of BCCP.
Study of the native BCCP linker gave a more complex picture in that deletion of the proline/alanine sequence adjacent to the domain had no effect on protein function. This lack of effect appears due to functional replacement of these residues with upstream proline/alanine sequences because introduction of arbitrary sequences adjacent to the domain blocked BCCP function. Therefore, the PDH linker seems to contain sequences that restrict the use of upstream residues as surrogates of those adjacent to the domain, whereas the native BCCP linker lacks this property. Since mobile linker and loop regions cannot be determined by the currently available techniques, the structures of such protein segments is a major unsolved problem of structural biology. In hopes of gaining structural insight, each of the linker sequences in this paper was submitted to the PSIPRED version 2.2 protein structure prediction program (available on the World Wide Web at bioinf. cs.ucl.ac.uk/psipred/). This program is considered to be the current state of the art for structure prediction from primary sequence (about 80% accurate). (Note that PSIPRED prediction of the BCCP biotinyl domain showed a highly accurate correspondence with the known domain structure, thus engendering confidence in the program.) None of the linker residue alterations reported in this paper changed the predicted pattern of secondary structure elements in wild type BCCP. The only changes seen were in the lengths of the linker regions (predicted as coil by the program). Thus, there are currently no data predicting which sequence or sequences can account for the differing "insulating" properties of the PDH and BCCP linkers.
It would have been advantageous to supplement the genetic
complementation data presented in this paper with assays of ACC activity. However, the ACC of E. coli readily dissociates
upon cell lysis, and hence the overall ACC activity cannot be measured in crude cell extracts (12, 13, 42).
| |
FOOTNOTES |
|---|
* This work was supported in part by National Institutes of Health Grant AI15650.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence may be addressed: Dept. of Microbiology,
University of Illinois, B103 Chemical and Life Sciences Laboratory, 601 S. Goodwin Ave., Urbana, IL 61801. Tel.: 217-333-7919; Fax: 217-244-6697; E-mail: j-cronan@life.uiuc.edu.
Published, JBC Papers in Press, April 15, 2002, DOI 10.1074/jbc.M201249200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
ACC, acetyl-CoA
carboxylase;
BCCP, biotin carboxyl carrier protein;
IPTG, isopropyl-
-D-thiogalactopyranoside;
X-gal, 5-bromo-4-chloro-3-indoyl-
-D-galactoside;
PDH, pyruvate
dehydrogenase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Perham, R. N. (2000) Annu. Rev. Biochem. 69, 961-1004[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Athappilly, F. K., and Hendrickson, W. A. (1995) Structure 3, 1407-1419[Medline] [Order article via Infotrieve] |
| 3. | Reddy, D. V., Shenoy, B. C., Carey, P. R., and Sonnichsen, F. D. (2000) Biochemistry 39, 2509-2516[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Roberts, E. L., Shu, N., Howard, M. J., Broadhurst, R. W., Chapman-Smith, A., Wallace, J. C., Morris, T., Cronan, J. E., Jr., and Perham, R. N. (1999) Biochemistry 38, 5045-5053[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Yao, X., Wei, D., Soden, C., Jr., Summers, M. F., and Beckett, D. (1997) Biochemistry 36, 15089-15100[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Yao, X., Soden, C., Jr., Summers, M. F., and Beckett, D. (1999) Protein Sci. 8, 307-317[Abstract] |
| 7. | Dardel, F., Davis, A. L., Laue, E. D., and Perham, R. N. (1993) J. Mol. Biol. 229, 1037-1048[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Green, J. D., Laue, E. D., Perham, R. N., Ali, S. T., and Guest, J. R. (1995) J. Mol. Biol. 248, 328-343[Medline] [Order article via Infotrieve] |
| 9. | Ricaud, P. M., Howard, M. J., Roberts, E. L., Broadhurst, R. W., and Perham, R. N. (1996) J. Mol. Biol. 264, 179-190[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Reche, P., and Perham, R. N. (1999) EMBO J. 18, 2673-2682[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Reed, L. J. (1998) Protein Sci. 7, 220-224[Medline] [Order article via Infotrieve] |
| 12. | Alberts, A. W., and Vagelos, P. R. (1972) in The Enzymes (Boyer, P. D., ed), 3rd Ed., Vol. 6 , pp. 37-82, Academic Press, Inc., New York |
| 13. |
Guchhait, R. B.,
Polakis, S. E.,
Dimroth, P.,
Stoll, E.,
Moss, J.,
and Lane, M. D.
(1974)
J. Biol. Chem.
249,
6633-6645 |
| 14. |
Li, S. J.,
and Cronan, J. E., Jr.
(1992)
J. Biol. Chem.
267,
16841-16847 |
| 15. |
Li, S. J.,
and Cronan, J. E., Jr.
(1992)
J. Biol. Chem.
267,
855-863 |
| 16. | Ohlrogge, J., Pollard, M., Bao, X., Focke, M., Girke, T., Ruuska, S., Mekhedov, S., and Benning, C. (2000) Biochem. Soc. Trans. 28, 567-573[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Green, J. D.,
Perham, R. N.,
Ullrich, S. J.,
and Appella, E.
(1992)
J. Biol. Chem.
267,
23484-23488 |
| 18. | Miles, J. S., Guest, J. R., Radford, S. E., and Perham, R. N. (1987) Biochim. Biophys. Acta 913, 117-121[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Miles, J. S., Guest, J. R., Radford, S. E., and Perham, R. N. (1988) J. Mol. Biol. 202, 97-106[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Perham, R. N., Duckworth, H. W., and Roberts, G. C. (1981) Nature 292, 474-477[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Radford, S. E., Laue, E. D., Perham, R. N., Miles, J. S., and Guest, J. R. (1987) Biochem. J. 247, 641-649[Medline] [Order article via Infotrieve] |
| 22. | Radford, S. E., Perham, R. N., Ullrich, S. J., and Appella, E. (1989) FEBS Lett. 250, 336-340[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Radford, S. E.,
Laue, E. D.,
Perham, R. N.,
Martin, S. R.,
and Appella, E.
(1989)
J. Biol. Chem.
264,
767-775 |
| 24. | Texter, F. L., Radford, S. E., Laue, E. D., Perham, R. N., Miles, J. S., and Guest, J. R. (1988) Biochemistry 27, 289-296[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Turner, S. L.,
Russell, G. C.,
Williamson, M. P.,
and Guest, J. R.
(1993)
Protein Eng.
6,
101-108 |
| 26. | Chambers, S. P., Prior, S. E., Barstow, D. A., and Minton, N. P. (1988) Gene (Amst.) 68, 139-149[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Pridmore, R. D. (1987) Gene (Amst.) 56, 309-312[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Cronan, J. E., Jr.
(2001)
J. Biol. Chem.
276,
37355-37364 |
| 29. |
Dennis, J. J.,
and Zylstra, G. J.
(1998)
Appl. Environ. Microbiol.
64,
2710-2715 |
| 30. |
Murtif, V. L.,
and Samols, D.
(1987)
J. Biol. Chem.
262,
11813-11816 |
| 31. |
Barker, D. F.,
and Campbell, A. M.
(1980)
J. Bacteriol.
143,
789-800 |
| 32. | Morris, T. W. (1994) Lipoate-Protein and Biotin-Protein Ligases of Escherichia ColiPh.D. thesis , University of Illinois, Urbana, IL |
| 33. | Amann, E., and Brosius, J. (1985) Gene (Amst.) 40, 183-190[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Hasan, N., Kur, J., and Szybalski, W. (1989) Gene (Amst.) 82, 305-311[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Chapman-Smith, A., and Cronan, J. E., Jr. (1999) Trends Biochem. Sci 24, 359-363[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Chapman-Smith, A.,
Morris, T. W.,
Wallace, J. C.,
and Cronan, J. E., Jr.
(1999)
J. Biol. Chem.
274,
1449-1457 |
| 37. |
Cronan, J. E., Jr.
(1988)
J. Biol. Chem.
263,
10332-10336 |
| 38. | Cronan, J. E., Jr., and Reed, K. E. (2000) Methods Enzymol. 326, 440-458[Medline] [Order article via Infotrieve] |
| 39. |
Best, E. A.,
and Knauf, V. C.
(1993)
J. Bacteriol.
175,
6881-6889 |
| 40. |
Marini, P., Li, S. J.,
Gardiol, D.,
Cronan, J. E., Jr.,
and de Mendoza, D.
(1995)
J. Bacteriol.
177,
7003-7006 |
| 41. | Brocklehurst, S. M., and Perham, R. N. (1993) Protein Sci. 2, 626-639[Abstract] |
| 42. |
Davis, M. S.,
Solbiati, J.,
and Cronan, J. E. Jr.
(2000)
J. Biol. Chem.
275,
28593-28598 |
| 43. | Chapman-Smith, A., Turner, D. L., Cronan, J. E., Jr., Morris, T. W., and Wallace, J. C. (1994) Biochem. J. 302, 881-887[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
B. Bagautdinov, Y. Matsuura, S. Bagautdinova, and N. Kunishima Protein Biotinylation Visualized by a Complex Structure of Biotin Protein Ligase with a Substrate J. Biol. Chem., May 23, 2008; 283(21): 14739 - 14750. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Dempsey, J. Nietfeldt, J. Ravel, S. Hinrichs, R. Crawford, and A. K. Benson Paired-End Sequence Mapping Detects Extensive Genomic Rearrangement and Translocation during Divergence of Francisella tularensis subsp. tularensis and Francisella tularensis subsp. holarctica Populations. J. Bacteriol., August 1, 2006; 188(16): 5904 - 5914. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Csizmok, E. Szollosi, P. Friedrich, and P. Tompa A Novel Two-dimensional Electrophoresis Technique for the Identification of Intrinsically Unstructured Proteins Mol. Cell. Proteomics, February 1, 2006; 5(2): 265 - 273. [Abstract] [Full Text] [PDF] |
||||